Patient Presents With Right Leg Pain
A 29-year-old woman presents with pain in the right leg. Radiographic imaging shows the presence of a lesion centered at the epiphysis of the femur. Surgical excision was performed. What is your diagnosis? (Source: Cancer Network)
Source: Cancer Network - July 8, 2013 Category: Cancer & Oncology Source Type: news

Bone Metastases in Lung Cancer Patients Linked With Poorer Prognosis
A pair of studies from the ASCO annual meeting examined bone metastases from lung cancer, with one study finding that survival in patients was poorer in patients with bone metastases, and another study finding that the development of bone metastases could predict subsequent development of metastasis in the brain. (Source: Cancer Network)
Source: Cancer Network - July 8, 2013 Category: Cancer & Oncology Source Type: news

Enlarged Spleen in 34-Year-Old Patient
A 34-year-old man presents with mild splenic enlargement. Resection of the spleen is performed. What is your diagnosis? (Source: Cancer Network)
Source: Cancer Network - July 8, 2013 Category: Cancer & Oncology Source Type: news

Young White Men More Likely Than Women to Die from Melanoma
Adolescent and young white men are at a more than 50% increased risk for death from melanoma than women of the same age, a new study has found. The researchers called the difference “alarming.” (Source: Cancer Network)
Source: Cancer Network - July 7, 2013 Category: Cancer & Oncology Source Type: news

Study: Red Meat Tied to Poor Colorectal Cancer Outcomes
A study of colorectal cancer survivors shows those who consume higher amounts of red and processed meats before a colorectal cancer diagnosis are at higher risk of death from any cause compared to those who eat less of both types of meat. (Source: Cancer Network)
Source: Cancer Network - July 4, 2013 Category: Cancer & Oncology Source Type: news

Recurrence After Tamoxifen Could Be Dictated by Gene Expression
The expression levels of two genes could indicate whether a woman with estrogen receptor-positive breast cancer is at risk for recurrence after 5 years of tamoxifen therapy and should receive subsequent therapy. (Source: Cancer Network)
Source: Cancer Network - July 3, 2013 Category: Cancer & Oncology Source Type: news

PHARE: One-Year Trastuzumab Remains Standard for HER2-Positive Breast Cancer
A 6-month regimen of treatment with trastuzumab for HER2-positive breast cancer failed to show noninferiority with the standard 12-month treatment regimen after 3.5 years of follow-up in the open-label, randomized, phase III PHARE trial. (Source: Cancer Network)
Source: Cancer Network - July 3, 2013 Category: Cancer & Oncology Source Type: news

Patient With Multiple Brain Metastases
A 59-year-old with a primary asymptomatic bronchogenic adenocarcinoma and multiple brain metastases. The patient was treated with cyclic chemotherapy consisting of: docetaxel (Taxotere), carboplatin, and bevacizumab (Avastin). What portion of the patient’s therapy is most likely responsible for the acne-like eruption? (Source: Cancer Network)
Source: Cancer Network - July 1, 2013 Category: Cancer & Oncology Source Type: news

Are You Special? Should We All Be Special?
If you or your loved one had cancer, how would you go about picking their treating oncologist? What would you want to know about their experience in that disease? And if a patient asks you how many cases you have treated with their diagnosis, will you look at them and be totally honest? (Source: Cancer Network)
Source: Cancer Network - June 30, 2013 Category: Cancer & Oncology Source Type: news

Boost in Use of Latest Technologies for Low-Risk Prostate Cancer Patients
From 2004 to 2009, use of advanced treatment technologies increased among prostate cancer patients with low-risk disease and high risk of noncancer mortality. (Source: Cancer Network)
Source: Cancer Network - June 29, 2013 Category: Cancer & Oncology Source Type: news

BRAF-Mutated Colon Cancer May Be Less Responsive to Aspirin's Positive Effects
An analysis of two colorectal cancer studies found that patients with BRAF mutations were less sensitive to the effects of aspirin as treatment or prevention. (Source: Cancer Network)
Source: Cancer Network - June 28, 2013 Category: Cancer & Oncology Source Type: news

Bone Metastases Result in Worse Outcomes for RCC Patients
Bone metastases result in poorer outcomes for those patients with advanced renal cell carcinoma (RCC), who were treated with a molecularly targeted therapy. The results were presented in two separate analyses at the annual ASCO meeting. (Source: Cancer Network)
Source: Cancer Network - June 27, 2013 Category: Cancer & Oncology Source Type: news

Tool Predicts Salivary Gland Cancer Recurrence Risk
Researchers have developed and tested a nomogram that uses various factors and can predict risk of recurrence in patients with major salivary gland carcinoma. (Source: Cancer Network)
Source: Cancer Network - June 27, 2013 Category: Cancer & Oncology Source Type: news

Ovarian Cancer Therapies in Development
Today we speak with Dr. Robert Coleman about several new agents that have shown promise in early-stage clinical trials for ovarian cancer. (Source: Cancer Network)
Source: Cancer Network - June 27, 2013 Category: Cancer & Oncology Source Type: news

Cost Effectiveness for Stage I Lung Cancer Therapies
Researchers found that the more cost-effective option (surgery vs SBRT) in stage I lung cancer depends on whether the disease is clearly or marginally operable. (Source: Cancer Network)
Source: Cancer Network - June 26, 2013 Category: Cancer & Oncology Source Type: news